Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 cm2 of the Face and Scalp in Patients with Actinic Keratosis: A Phase 3 Study. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Jan. 23];7(6):s264. Available from: https://skin.dermsquared.com/skin/article/view/2335